Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shedir Pharma Srl Unipersonale
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Cash from Investing Activities
-€11.2m
CAGR 3-Years
-126%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Cash from Investing Activities
€5.3m
CAGR 3-Years
-9%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Cash from Investing Activities
-€51m
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
10%
P
Pierrel SpA
MIL:PRL
Cash from Investing Activities
-€10.1m
CAGR 3-Years
-32%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Cash from Investing Activities
-€6.9m
CAGR 3-Years
-37%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Cash from Investing Activities?
Cash from Investing Activities
-11.2m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Cash from Investing Activities amounts to -11.2m EUR.

What is Shedir Pharma Srl Unipersonale's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-31%

Over the last year, the Cash from Investing Activities growth was -305%. The average annual Cash from Investing Activities growth rates for Shedir Pharma Srl Unipersonale have been -126% over the past three years , -31% over the past five years .

Back to Top